BCRX Latest Headlines

BioCryst Achieves Record Profitability and Advances Hereditary Angioedema Portfolio with Strategic Moves in 2025

Market Chameleon (Thu, 26-Feb 7:43 AM)

BioCryst Highlights Expanding HAE Portfolio with Nine New Abstracts – What Does the Latest Data Reveal?

Market Chameleon (Wed, 11-Feb 8:32 AM)

BioCryst Shatters Revenue Guidance with ORLADEYO—2025 Net Sales Up 37%, 2026 Outlook Remains Strong

Market Chameleon (Mon, 12-Jan 7:54 AM)

FDA Approves BioCryst's ORLADEYO Oral Pellets: Transforming HAE Care for Young Children

Market Chameleon (Fri, 12-Dec 7:52 AM)